TY - JOUR
T1 - Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma
AU - Batchelor, Tracy T.
AU - Betensky, Rebecca A.
AU - Esposito, J. Matthew
AU - Pham, Loc Duyen D.
AU - Dorfman, Molly V.
AU - Piscatelli, Nicole
AU - Jhung, Sarah
AU - Rhee, David
AU - Louis, David N.
PY - 2004/1/1
Y1 - 2004/1/1
N2 - Purpose: Although the genetic alterations in glioblastoma have been well characterized, reports regarding their prognostic effects have been inconsistent. Experimental Design: In this series of 140 consecutive cases of glioblastoma treated at a single center, we analyzed the frequency, age dependency and prognostic effects of TP53 mutation, CDKN2A/p16 deletion, EGFR amplification, as well as loss of chromosome 1p, chromosome 10q, and chromosome 19q. The complete set of genetic alterations was available on 60 of 140 patients. Results: In this cohort of glioblastoma cases, TP53 mutation was significantly associated with patient age. The prognostic effects of TP53 mutation, EGFR amplification, CDKN2A/p16 alterations, and loss of chromosome 1p were dependent on the age of the patient. Conclusions: This is the first observation that the prognostic effects of TP53, 1p, and CDKN2A/p16 alterations are dependent on patient age. These observations concerning the interactions of age and genetic changes in glioblastoma suggest that tumorigenic pathways to glioblastoma vary with the age of the patient and that future molecular marker studies should carefully evaluate the potential age-dependent prognostic effects of these biological variables. The inconsistent or negative prognostic effects of molecular markers reported in prior studies of glioblastoma may be because different effects at different ages may have resulted in a cancellation of an overall effect in the entire cohort.
AB - Purpose: Although the genetic alterations in glioblastoma have been well characterized, reports regarding their prognostic effects have been inconsistent. Experimental Design: In this series of 140 consecutive cases of glioblastoma treated at a single center, we analyzed the frequency, age dependency and prognostic effects of TP53 mutation, CDKN2A/p16 deletion, EGFR amplification, as well as loss of chromosome 1p, chromosome 10q, and chromosome 19q. The complete set of genetic alterations was available on 60 of 140 patients. Results: In this cohort of glioblastoma cases, TP53 mutation was significantly associated with patient age. The prognostic effects of TP53 mutation, EGFR amplification, CDKN2A/p16 alterations, and loss of chromosome 1p were dependent on the age of the patient. Conclusions: This is the first observation that the prognostic effects of TP53, 1p, and CDKN2A/p16 alterations are dependent on patient age. These observations concerning the interactions of age and genetic changes in glioblastoma suggest that tumorigenic pathways to glioblastoma vary with the age of the patient and that future molecular marker studies should carefully evaluate the potential age-dependent prognostic effects of these biological variables. The inconsistent or negative prognostic effects of molecular markers reported in prior studies of glioblastoma may be because different effects at different ages may have resulted in a cancellation of an overall effect in the entire cohort.
UR - http://www.scopus.com/inward/record.url?scp=1642453725&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1642453725&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-0841-3
DO - 10.1158/1078-0432.CCR-0841-3
M3 - Article
C2 - 14734474
AN - SCOPUS:1642453725
SN - 1078-0432
VL - 10
SP - 228
EP - 233
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 1 I
ER -